Stock Earnings
CRVS stock rated a Buy by H.C. Wainwright
Corvus Pharmaceuticals Inc’s filing revealed that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on Jun
Menu
Corvus Pharmaceuticals Inc’s filing revealed that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on Jun
In a filing, Corvus Pharmaceuticals Inc revealed its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on
In a filing, Corvus Pharmaceuticals Inc revealed its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on
In a filing, Corvus Pharmaceuticals Inc revealed its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on
Corvus Pharmaceuticals Inc’s filing revealed that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on Jun
Corvus Pharmaceuticals Inc’s recent filing unveils that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Corvus Pharmaceuticals
Corvus Pharmaceuticals Inc’s recently made public that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on